Wnt pathway is involved in 5fu drug resistance of colorectal. The development of multidrug resistance mdr to chemotherapy remains a major challenge in the treatment of cancer. Hailed as the cancer treatment to end all the resistance to treatment, antiangiogenic therapy turned out to be not quite what was promised. Either intrinsic or acquired resistance are associ ated with cellular or noncellular mechanisms such as tumor microenvironment, tumor size and accessibility of drugs to cancerous cells, extracellular factors and vasculature 6,10, 11. Pdf mechanisms of drug resistance in cancer chemotherapy. The role and mechanisms of action of micrornas in cancer drug. A new mechanism of drug resistance in breast cancer cells.
Cancer tumors gain drug resistance by eating dead cells. Cancer drug resistance is an open access journal, focusing on pharmacological aspects of drug resistance and its reversal, molecular mechanisms of drug resistance and drug classes, etc. The most common reason for acquisition of resistance to a broad range of anticancer drugs is expression of one or more energydependent transporters that detect and eject anticancer drugs from cells, but other mechanisms of resistance including insensitivity to druginduced apoptosis and induction of drugdetoxifying mechanisms probably play an important role in acquired anticancer drug resistance. Ma3 abstract the biggest hurdle to targeted cancer therapy is the inevitable emergence of drug resistance. This means that the same dose which decreases the tumor burden from 106 to 103 cells will be needed to decrease the burden from 103 to 100 cells. The mutant subpopulation is selected by growth in presence of drug. Mar 12, 2018 cancer drug resistance is an open access journal, focusing on pharmacological aspects of drug resistance and its reversal, molecular mechanisms of drug resistance and drug classes, etc. Despite the fact that a wide scope of anticancer drugs, including researchbased agents and medications confirmed for human use, is accessible. Better understanding the mechanisms of drug resistance is required to provide guidance to future cancer treatment and achieve better outcomes. The moonshot drug resistance and sensitivity network, was established to develop innovative strategies and study mechanisms of tumor resistance or sensitivity to anticancer therapies that ultimately inform precision medicine clinical trials that can overcome drug resistance to anti cancer agents.
One of the main causes of failure in the treatment of cancer is the development of drug resistance by the cancer cells. The underlying mechanism of acquired resistance, for 10 years, was thought to be related to the multi drug resistance gene mdr 1. The development of intrinsic and acquired drug resistance in cancer is a major obstacle for effective therapeutic treatment. Some of the knowledge about drug resistance has revealed new mechanisms relevant to normal handling of drugs by the body, and this information will. In this issue of cancer research, finn and colleagues demonstrate that modeling acquired resistance to met tyrosine kinase inhibition in a met. Genetic mechanisms of drug resistance 89 resulting in drug resistance can occur in the presence but also in the absence of drug. There are several mechanisms including inactivation of the drug, multidrug resistance, inhibiting cell death apoptosis suppression, changes in. The hope that this therapeutic approach would not have suffered by the phenomenon of resistance was based on. Drug resistance mechanisms in japanese anaplastic lymphoma. Alteration of drug targets a drug s efficacy is influenced by its molecular target and alterations of this target, such as mutations or modifications of expression levels.
Apoptosis and antiapoptosis pathways are also deeply related to drug sensitivity and resistance. Despite the development of new targeted anticancer therapies, mechanisms that have evolved in mammals to protect cells against cytotoxic compounds in the environment will continue to act as obstacles to successful. Harvardmit division of health sciences and technology 151. Mechanisms of multidrug resistance in cancer springerlink. Understanding the genetic mechanisms of cancer drug resistance. Cancer, dna repair mechanisms, and resistance to chemotherapy. These molecularly targeted therapies have had varying degrees of success because a diverse range of resistance mechanisms have limited patient responses.
The drug resistance in breast cancer shares most traits with other solid tumours. It has been approximately ten years since the food and drug administration fda approved paclitaxel for the treatment of. Drug resistance of cancer chemotherapy can be caused by many mechanisms, such as. It has been recognized that multidrug resistance is multifactorial and that various cellular pathways might be simultaneously involved in the clinical drug resistance of cancer patients. The ability of cancer cells to become crossresistant to structurally and functionally unrelated anti cancer drugs is known as multidrug resistance. Mechanisms of drug resistance in cancer chemotherapy. Review article molecular mechanisms of drug resistance. Overall, drug inactivation is a mechanism of cancer drug resistance that warrants further investigation.
Diverse resistance mechanisms to the thirdgeneration alk. The term is used in the context of resistance that pathogens or cancers have acquired, that is, resistance has evolved. The mechanisms of drug resistance in the cancer cells. Additional knowledge about these mechanisms of cancer drug resistance may help to design strategies to circumvent resistance and new drugs that are less susceptible to known resistance mechanisms. As a result of studies of cell lines and animal tumours a number of drug resistance. Resistance constitutes a lack of response to drug induced tumour growth inhibition. Tumor heterogeneity may also contribute to resistance.
Chemotherapy resistance mechanisms ulrik ringborg and anton platz resistance to chemotherapy is a major problem in on cology. A large body of research has established multidrug resistance mdr transporter proteins as one of the key mechanisms of cancer cell resistance to chemotherapy drugs 36, particularly anthracyclines and taxanes. In this study, we analyzed resistance mechanisms through serial tumor biopsy in japanese patients during sequential treatment with alktki and revealed the sequential transition of resistance mechanisms, particularly those associated with the use of firstline. Understanding the genetic mechanisms of cancer drug. Johnston abstract resistance to chemotherapy and molecularly targeted therapies is a major problem facing current cancer research. The tumour microenvironment is also emerging as a key mediator of drug resistance, with experimental data revealing a tremendous degree of stromal adaptation, potentially mediated by cancer cell signalling activity, to circumvent drug effects. One of the main causes behind the failure of treatment is the development of various therapy resistance mechanisms by the cancer cells leading to the recurrence of the disease. It has been recognized that multidrug resistance is multifactorial and that various cellular pathways might be simultaneously involved in the clinical drug resistance of cancer. The molecular mechanisms of drug resistance, however, are not fully understood. Investigating new mechanisms of acquired resistance to. Drug resistance and combating drug resistance in cancer. Targeted therapies have revolutionized treatment of several different types of cancers. Therapyinduced resistance appears more common and more challenging. Understanding the genetic mechanisms of cancer drug resistance using genomic approaches xueda hu1 and zemin zhang1,2, a major obstacle in precision cancer medicine is the inevitable resistance to targeted therapies.
Deciphering resistance to immunotherapy requires an understanding of the interplay between mechanisms that are intrinsic to cancer cells and. Mechanisms of hb resistance to platinum derivatives. When the dnadamage signaling pathway was discovered, the many signaling molecules were found to be critical. Resistance mechanisms to drug therapy in breast cancer and. A major objective of this book is to reveal unprecedented opportunities to understand and overcome drug resistance through the clinical assessment of rational therapeutic drug combinations and the use of predictive and prognostic biomarkers to enable patient stratification and tailor treatments. The interaction between two signaling pathways may be related to resistance to a leading cancer drug in colorectal cancer cells.
Pdf the management of cancer involves surgery, radiotherapy and chemotherapy. Drug resistance of cancer cells to chemotherapy can be inherent or developed through exposure to the drug 36. Cancer cells will become resistant to drugs by the mechanisms such as the inactivation of the drug, multi drug resistance, cell death inhibition apoptosis suppression, altering in the drug metabolism, epigenetic changing, changes in the. Clinically, resistance can arise prior to or as a result of cancer therapy. Overall, drug inactivation is a mechanism of cancer drug resistance that. Importantly, the mechanisms of resistance to cytotoxic. Also, the cancer drug resistance is acquired, the drug resistance can be occurred by different mechanisms, including multi drug resistance, cell death inhibiting apoptosis suppression, altering in the drug metabolism, epigenetic and drug targets, enhancing dna repair and gene amplification. This section is intended to introduce some of the main ways in which cancer cells can resist treatments. The role and mechanisms of action of micrornas in cancer. Drug resistance can occur at many levels, including increased drug.
Cancer is a leading cause of death worldwide accounting to % of all deaths. Despite numerous drug combinations and regimens, all patients with advanced breast cancer, similarly to other solid tumors, inevitably develop resistance to treatment. Platinumbased anticancer drugs are commonly administered in combination regimens used for the treatment of several solid tumors, including liver cancers. Resistance exists against every effective anticancer drug and can develop by numerous mechanisms including decreased drug uptake, increased drug efflux, activation of detoxifying systems, activation of dna repair mechanisms, evasion of drug induced apoptosis, etc. Circumventing cancer drug resistance in the era of. Review open access emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy zuanfu lim1,2,3 and patrick c. There are multiple mechanisms causing drug resistance in cancer cells among and within cancer types. Pdf anticancer drugs resistance is a complex process that arises from altering in the drug targets. However, in almost an invariable fashion, cancers eventually regrow in the presence of the targeted therapy, a phenomenon referred to as acquired resistance.
Anticancer drugs resistance is a complex process that arises from altering in the drug targets. The mechanisms of resistance to classical cytotoxic. Mechanisms of resistance to imatinib and secondgeneration. Drug resistance is the reduction in effectiveness of a medication such as an antimicrobial or an antineoplastic in treating a disease or condition. Mechanisms of acquired crizotinib resistance in alk. Various mechanisms of resistance, such as abc transportermediated drug efflux, have been discovered using established model cancer cell lines. The drug 5fluorouracil 5fu is widely used to limit malignant. Brockman a former head of the drug resistance section of the southern research institute completed an approximately 100page book chapter describing in detail the knowledge of anticancer drug resistance mechanisms at that time. Thus, understanding exosome biogenesis, their contents and the molecular mechanisms and signaling pathways that are responsible for metastasis and drug resistance mediated by tdes may help to devise novel therapeutic approaches for cancer progression particularly to. Review feedback activation of stat3 as a cancer drugresistance mechanism chengguang 1, zhao,1,2,3,5 huameng li,3,5 hueyjen lin,4 shulin yang, jiayuh lin,2, and guang liang3 signal transducer and activator of transcription 3 stat3 plays crucial roles in. Antimicrobial resistance and antineoplastic resistance challenge clinical care and drive research.
The different mechanisms of cancer drug resistance. Mechanisms of drug resistance in acute myeloid leukemia. Feedback activation of stat3 as a cancer drugresistance. Emphasis will be placed on pathways involved in cisplatin resistance since this drug is currently the cornerstone in the che motherapy of advancedstage ovarian cancer. Statistical data indicate that over 90% of the mortality of patients with cancer is related to drug resistance. Breast cancer is the most common solid tumor in women.
Assuming an initial tumor burden of 106 cells, a treatment which is 99. Some of the knowledge about drug resistance has revealed new mechanisms relevant to normal handling of drugs by the body, and this information will be important in improving drug delivery and. Lung cancer drug resistance and dna damage signaling. In addition to high expression on hematopoietic primitive cells, both abcb1 and abcg2 show tissue localization in the small bowel, brain, testes, and canalicular membrane of hepatocytes and may contribute to imatinib resistance by causing drug efflux from cells from these sites.
Molecular drug resistance mechanisms in prostate cancer. Lorlatinib is a thirdgeneration anaplastic lymphoma kinase alk tyrosine kinase inhibitor with proven efficacy in patients with alkrearranged lung cancer previously treated with first and secondgeneration alk inhibitors. We revealed that alkpositive lung cancer cells, treated with crizonitib, a molecular target drug, acquired resistance to the drug not only by genetic mutation but also by concomitant epithelial. Researchers at the university of california, irvine, have discovered a new mechanism that explains how some tumors can develop resistance to certain cancer drugs.
If a single cell line is capable of yielding multiple mechanisms of resistance, it is not surprising that a cancer that develops in a patient has a similar capacity. Beside compound mutations in the alk kinase domain, other resistance mechanisms driving lorlatinib resistance remain unknown. Key words cancer, multidrug resistance, abc transporters, drug transport, chemotherapy s abstract the design of cancer chemotherapy has become. Cisplatin was the first described platinum derivative and is a key drug in hb treatment, leading in some cases to improved resectability and longer patient survival. Aug 14, 2018 the interaction between two signaling pathways may be related to resistance to a leading cancer drug in colorectal cancer cells. Both clinical and experimental aspects of drug resistance in cancer are included. Cancer drug resistance continues to be a major impediment in medical oncology. Cancer drugresistance overview the development of targeted therapies has brought much promise to overcoming cancer as a compendium to of different genomic diseases 1.
This is a very serious problem that may lead to recurrence of disease or even death. In vitro analysis confirmed that the erbb2 mutations conferred estrogen independence and. Drug resistance of cancer chemotherapy can be caused by many mechanisms, such as decreased antitumor drug uptake, modified drug targets, altered cell cycle checkpoints, or increased dna damage repair, among others. Studies on mechanisms of cancer drug resistance have yielded important information. Expression of a major vault protein, termed lung resistancerelated protein lrp, which may regulate nuclear entry of drugs, has also been described in multidrug resistance 11a. The goal of this funding opportunity announcement foa is to create a network of drug resistance and sensitivity centers drscs. A great deal is now known about mechanisms of drug resistance in cancer cells. While characterizing a drug resistant breast cancer cell line, mcf7advp3000, we found that fatty acid synthase fasn is overexpressed. Multidrug resistance is a major problem in successful cancer chemotherapy. Many of the drugs used in cancer chemotherapy are most effective against rapidly proliferating malignancies tidd, 1984.
Mechanisms and insights into drug resistance in cancer. Tremendous effort and progress has been made over the past few years to understand the biochemical and genetic mechanisms under. As mutations are in principle irreversible, the resistance is retained if the cells are grown without drug. Mar 14, 20 cancer drug resistance continues to be a major impediment in medical oncology.
Drug resistance in cancer an overview sciencedirect topics. Mechanisms of anticancer drug resistance in hepatoblastoma. Systemic therapy often results in the reduction of tumor size but rarely succeeds in eradicating all cancer cells. Drug resistance in cancer chemotherapy is one of the main obstacles to curing this malignant disease.
These drscs will be expected to conduct preclinical research focused on innovative strategies to understand and combat mechanisms of tumor resistance intrinsic or acquired andor to exploit tumor sensitivity to anti cancer therapies. Mechanisms of acquired tumor drug resistance sciencedirect. Review open access the role and mechanisms of action of micrornas in cancer drug resistance wengong si1,2,3, jiaying shen4, huilin zheng1,5 and weimin fan1,6 abstract micrornas mirnas are small noncoding rnas with a length of about 1925nt, which can regulate various target. Pdf the different mechanisms of cancer drug resistance. Identified mechanisms of resistance could be classified into intra and. The same eml4alk cell line, h3122, developed three different mechanisms of resistance.
759 837 1309 469 1431 1569 955 1420 1147 789 424 235 262 944 816 1096 954 1082 1200 115 510 593 321 1469 317 1057 1506 1123 880 412 645 1236 183 16 568 1397 702 537 1349 1274 724